Artificial Intelligence in Medicine: Hope or Hype?

The application of AI in the medical field holds great promise for improving patient health, but will doctors and patients feel comfortable using it? Young startups have begun leveraging this technology to prove better health outcomes, but there's still a lot to do.
Read More

Best Practices In FDA Orphan Drug Submissions

Since 1983, pharmaceutical developers have been incentivized by the FDA via an Orphan Drug Designation (ODD) program. The program awards orphan status to drugs that show likelihood of benefitting an afflicted population that might not otherwise be the focus of development efforts.
Read More